新型抗精神病药氨磺必利
沈一峰,李华芳,顾牛范
摘要(Abstract)：
关键词(KeyWords)：
基金项目(Foundation):
作者(Author): 沈一峰,李华芳,顾牛范
DOI: 10.19577/j.cnki.issn10074406.2000.02.027
参考文献(References)：
- [1] Schoem aker H,Claustre Y,Fage D,et al. Neurochemicalcharacter-ristics of amisulpride,an atypical dopamine D2 /D3receptor antagonist with both presynaptic and lim biselectivity.JPharmacol Exp Ther,1997,2 80 (1) :83
- [2 ] Cudennec A,Fage D,Benavides J,et al.Effects of amisulpride,an atypical antipsychotic which blocks preferentially presynapticdopam ine autoreceptors,on integrated functional cerebralactivity in the rat.Brain Rec,1997,76 8(1-2 ) :2 5 7
- [3] Trichard C,Paillere-Martinot ML ,Attar-L evy D,et al.Bindingof antipsychotic drugs to cortical5 -HT2 Areceptors:a PET sutdyof chlorprom azine,clozapine,and amisulpride in schizophrenicpatients.Am JPsychiatry,1998,15 5 (4) :5 0 5
- [4] Hamon-Vilcot B,Chaufour S,Deschamps C,et al. Safety andpharmacokinetics of a single oral dose of amisulpride in healthyelderly volunteers.Eur JClin Pharmacol,1998,5 4(5 ) :40 5
- [5 ] Chabannes JP,Pelissolo A,Farah S,et al.Evaluation of efficacyand tolerance of amisulpride in treatment of schizophrenicpsychoses.Encephale,1998,2 4(4) :386
- [6 ] Puech A,Fleurot O,Rein W.Am isulpride,and atypicalantipsychotic,in the treatment of acute episodes ofschizophrenia:a dose-ranging study vs haloperidol.ActaPsychiatr Scand,1998,98(1) :6 6
- [7] Wetzel H,Grunder G,Hillert A,et al. Amisulpride versusflupentixol in schizophrenia with predominantly positivesym ptom atology-a double-blind controlled study com paring aselective D2 -like antagonist to a mixed D1 -/D2 -like antagonist.Psychopharmacology(Berl) ,1998,137(3) :2 2 3
- [8] Rein W,Turjanski S.Clinical update on am isulpride in deficitschizophrenia.Int Clin Psychopharmacol,1997,12 (Suppl) 2 :19
- [9] Danion JM,Rein W,Fleurot O. Improvements of schizophrenicpatients with primary negative symptoms treated withamisulpride. Am JPsychiatry,1999,15 6 (4) :6 10
- [10 ] Ravizza L.Amisulpride in medium-term treatmentof dysthymiaa six-month,double blind safety study versus amitriptyline.Jpsychopharmacol,1999,13(3) :2 48
- [11] Sm eraldi E.Amisulpride versus fluoxetine in patients withdysthymia or m ajor depression in partial remission:a double-blind,comparative study.JAffect Disord,1998,48(1) :47
- [12 ] Lecrubier Y,Boyer P,Turjanski S,et al. Amisulpride versusimipramine and placebo in dysthym ia and major depression.JAffect Disord,1997,43(2 ) :95
- [13] Ramaekers JG,Louwerens JW,Muntjewerff ND,et al.Psychomotor,cognitive,extrapyramidal,and affectivefunctions of healthy volunteers during treatment with anatypical (amisulpride) and a classic (haloperidol)antipsychotic.JClin Psychopharm acol,1999,19(3) :2 0 9
- [14 ] Mattila MJ,Patat A,Seppala T,et al.Single oral doses ofamisulpride do not enhance the effects of alcohol on theperform ance and m emory of healthy subjects. Eur J ClinPharmacol,1996 ,5 1(2 ) :16 1
- [15 ] Souetre E,Martin P,Lecanu JP,et al. Medico-economicassessment of neuroleptics in schizophrenia.Amisulprideversus haloperidol.Encephale,1992 ,18(3) :2 6 3